Why the study?
The mechanisms underlying the anti-apoptotic effects of G-CSF in diabetic cardiomyopathy were not fully understood.
Does granulocyte-colony stimulating factor (G-CSF) reduce cardiomyocyte apoptosis by up-regulating autophagy in a model of diabetic cardiomyopathy?
Population
Rats with induced diabetic cardiomyopathy and high-glucose cultured rat H9c2 cardiac cells
Comparison
G-CSF treatment vs control or autophagy inhibition
Design
In vivo and in vitro animal experimental study
Authors
Loading...
Autophagy may mediate G-CSF anti-apoptotic effects in diabetic cardiomyopathy models; hypothesis-generating, clinical translation untested.
Does granulocyte-colony stimulating factor (G-CSF) reduce cardiomyocyte apoptosis by up-regulating autophagy in a model of diabetic cardiomyopathy?
G-CSF attenuates cardiomyocyte apoptosis in diabetic cardiomyopathy by up-regulating autophagy, highlighting a potential mechanistic pathway for treating diabetic heart disease.
Shen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: